LRRK2 and Parkinson disease: Mutation of the LRRK2, G2019S, could reduce mitophagy in PD, which can promote ROS-induced dopaminergic neuronal death, and the application of truncated LRRK2 reverses ROS accumulation and prevents neuronal injury58.